Skip to main content
Top
Published in: Journal of the International AIDS Society 3/2010

Open Access 01-12-2010 | Oral presentation

Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1

Authors: BD Kuhl, RD Sloan, DA Donahue, T Bar-Magen, C Liang, MA Wainberg

Published in: Journal of the International AIDS Society | Special Issue 3/2010

Login to get access

Excerpt

Tetherin (BST-2/CD317/HM1.24) is an interferon-inducible factor of the innate immune system, recently shown to exert antiviral activity against HIV-1 and other enveloped viruses by tethering nascent viral particles to the cell surface, thereby inhibiting viral release. In HIV-1 infection, the viral protein U (Vpu) counteracts this antiviral action by down-modulating tetherin from the cell surface. Viral transmission between T cells can occur via cell-free transmission or the more efficient direct cell-cell route through virological synapses. Virological synapses are associated with lipid raft-rich microdomains in the membrane. Tetherin is known to localize to these microdomains and is capable of modulating actin architecture, which is crucial for viral entry, assembly and budding. …
Metadata
Title
Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1
Authors
BD Kuhl
RD Sloan
DA Donahue
T Bar-Magen
C Liang
MA Wainberg
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S3-O8

Other articles of this Special Issue 3/2010

Journal of the International AIDS Society 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.